AEGLEA BIOTHERAPEUTICS, INC. Common Stock ($0.0001 par value per share) Capital on Demand™ Sales AgreementAeglea BioTherapeutics, Inc. • May 1st, 2017 • Pharmaceutical preparations • New York
AEGLEA BIOTHERAPEUTICS, INC. a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JONESTRADING INSTITUTIONAL SERVICES LLC (the “Agent”), as follows:
